PB
Invesco Biotechnology & Genome Fund (PBE)
BMV
1,400.00
0.00 (0.00%)
Closed
Aug 24, 2026
Day's Range
1,400.001,400.00
52 wk Range
1,113.101,400.00
Overview - PBE - Invesco Biotechnology & Genome Fund
Key Statistics
Valuation
P/E (Trailing)
‪3.11‬
Price stats
50-Day Avg
‪1,400.00‬
200-Day Avg
‪1,378.91‬
Dividends
Frequency
Annual
Market Cap - PBE - Invesco Biotechnology & Genome Fund
Peers - PBE - Invesco Biotechnology & Genome Fund
Peer Comparison
Compared with other ETFs.
- PBEBMVInvesco Biotechnology & Genome Fund6.33BMarket Cap+20.49%52-week change3.11P/E (Trailing)—Profit Margin
- SPSPYBMVSPDR S&P 500 ETF Trust11.59TMarket Cap+6.93%52-week change6.73P/E (Trailing)—Profit Margin
- IVVBMViShares Core S&P 500 ETF7.86TMarket Cap+7.29%52-week change4.68P/E (Trailing)—Profit Margin
- QQQBMVInvesco QQQ Trust4.61TMarket Cap+11.21%52-week change7.71P/E (Trailing)—Profit Margin
- IWIWFBMViShares Russell 1000 Growth ETF2.38TMarket Cap-300.14%52-week change1.04P/E (Trailing)—Profit Margin
- GLDBMVSPDR Gold Trust1.97TMarket Cap+19.85%52-week change—P/E (Trailing)—Profit Margin
- EFABMViShares MSCI EAFE ETF1.69TMarket Cap+6.80%52-week change34.42P/E (Trailing)—Profit Margin
Profile Summary - PBE - Invesco Biotechnology & Genome Fund
About
The Invesco Biotechnology & Genome Fund is an exchange-traded fund (ETF) designed to offer investors exposure to the biotechnology and genomic sectors. Its primary function is to track the performance of the Dynamic Biotech & Genome Intellidex Index, which is composed of securities of U.S. biotechnology and genome…
Employees0
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
